Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
BackgroundReduced or absent H antigens on red cells with the (para‐)Bombay phenotype can arise from FUT1 gene mutations, impacting the structure and function of 1,2‐L‐fucosyltransferase 1 (1,2‐L‐FucT1). Here, we identified the novel mutations in one patient displaying the para‐Bombay phenotype and examined the potential molecular mechanisms underlying this phenotype.Materials and MethodsABH antigens and antibodies were detected in patient's blood and saliva using serological methods. The genotypes of ABO, FUT1, and FUT2 were imputed using the genetic variations discovered in the whole exome sequencing data. Three‐dimensional (3D) models of FUT1 variants were built using Deepmind's AlphaFold2 and HDOCK, and the possible effects of the variants were predicted to evaluate using DynaMut2 and Polyphen‐2.ResultsSerological analysis confirmed the para‐Bombay B phenotype producing anti‐HI and exhibiting normal genotypes ABO*B.01/O.01.02 and FUT2*01.09/01.09. Remarkably, the phenotype is caused by a compound heterozygous genotype: one allele containing the novel c.–35A>T mutation and the known c.725T>G mutation (p.Leu242Arg) of FUT1, and the other allele containing the c.–35A>T mutation. From the computerized stimulation analysis, p.Arg242 of the FUT1 variant may be detrimental, destabilizing, and probably damaging to 1,2‐L‐FucT1, although not altering the 3D structure of the entire enzyme. The c.–35A>T promoter DNA left at the binding interface of both ZID and c‐Rel transcription factors may enable regulation of 1,2‐L‐FucT1 function at gene promoters.ConclusionWe identified the two novel variants, c.–35A>T and c.[−35A>T, 725T>G], in the FUT1 causing the para‐Bombay phenotype. This finding may clarify the molecular mechanisms and enhance blood transfusion safety.
BackgroundReduced or absent H antigens on red cells with the (para‐)Bombay phenotype can arise from FUT1 gene mutations, impacting the structure and function of 1,2‐L‐fucosyltransferase 1 (1,2‐L‐FucT1). Here, we identified the novel mutations in one patient displaying the para‐Bombay phenotype and examined the potential molecular mechanisms underlying this phenotype.Materials and MethodsABH antigens and antibodies were detected in patient's blood and saliva using serological methods. The genotypes of ABO, FUT1, and FUT2 were imputed using the genetic variations discovered in the whole exome sequencing data. Three‐dimensional (3D) models of FUT1 variants were built using Deepmind's AlphaFold2 and HDOCK, and the possible effects of the variants were predicted to evaluate using DynaMut2 and Polyphen‐2.ResultsSerological analysis confirmed the para‐Bombay B phenotype producing anti‐HI and exhibiting normal genotypes ABO*B.01/O.01.02 and FUT2*01.09/01.09. Remarkably, the phenotype is caused by a compound heterozygous genotype: one allele containing the novel c.–35A>T mutation and the known c.725T>G mutation (p.Leu242Arg) of FUT1, and the other allele containing the c.–35A>T mutation. From the computerized stimulation analysis, p.Arg242 of the FUT1 variant may be detrimental, destabilizing, and probably damaging to 1,2‐L‐FucT1, although not altering the 3D structure of the entire enzyme. The c.–35A>T promoter DNA left at the binding interface of both ZID and c‐Rel transcription factors may enable regulation of 1,2‐L‐FucT1 function at gene promoters.ConclusionWe identified the two novel variants, c.–35A>T and c.[−35A>T, 725T>G], in the FUT1 causing the para‐Bombay phenotype. This finding may clarify the molecular mechanisms and enhance blood transfusion safety.
Background and ObjectivesRecently, third‐generation long‐read sequencing technology has been increasingly applied to the detection of various blood group systems. Because of its long read length and use of single‐molecule sequencing, it is capable of obtaining the sequences of blood group genes in their entirety as well as of distinguishing haplotypes. Therefore, here, we collected ABO blood group samples that were difficult to classify serologically and analysed the sequences of the coding regions of the ABO genes as well as the sequences upstream and downstream of the coding regions.Materials and MethodsSamples with ABO antigen typing and reverse serum typing discrepancies were screened in a total of 21 patients. All samples were subjected to serological testing and preliminary ABO genotyping (polymerase chain reaction with sequence‐specific primers [PCR‐SSP]), followed by single‐molecule real‐time (SMRT) sequencing to obtain complete ABO gene sequences. PCR sequence‐based typing (PCR‐SBT) was performed to validate the results.ResultsOf the 21 samples, 15 had common ABO types, and 6 had rare ABO subtypes. One new allele, ABO*B.NEW (c.861C>T), and one allelic base recombination event was identified. Forty‐two haplotype sequences were obtained via SMRT sequencing with intronic single‐nucleotide variants (SNVs) specific to the ABO allele, and all of the exon region sequences were consistent with the PCR‐SBT results.ConclusionSMRT sequencing is capable of accurately obtaining complete ABO gene sequences, distinguishing haplotypes and identifying allelic recombination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.